NCT00315601View on ClinicalTrials.gov

Intrapulmonary Pharmacokinetics of Antibiotics

PHASE4TerminatedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Healthy
Interventions
DRUG

Telithromycin

800 mg once a day for 5 days

DRUG

azithromycin

500 mg on day 1, and then 250 mg once-daily on days 2 through 5

PROCEDURE

bronchoalveolar lavage

One bronchoscopy with bronchoalveolar lavage with each drug administration

DRUG

Telithromycin

Telithromycin 800 mg once a day

Trial Locations (1)

85006

Pulmonary Associates PA, Phoenix

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University of Illinois at Chicago

OTHER